Proposed AHRQ Cut Raises Questions About Infection Prevention Research and Support

President Donald Trump’s administration has proposed canceling $27.7 million in funding for the Agency for Healthcare Research and Quality (AHRQ), placing an agency with an infection prevention role across health care settings within a federal spending dispute.

The September 25 announcement concerns rescinding appropriated funding, not reversing earlier cuts. Trump’s message to Congress lists 11 proposed rescissions totaling $810 million. Other Health and Human Services (HHS) reductions include $567,401,904 from Refugee and Entrant Assistance and $5,098,000 from the Office of the Secretary account, targeting Office of Minority Health activities.

The AHRQ proposal would remove $27,700,000 from its $345 million fiscal year 2026 appropriation. The administration describes the action as “a first step to prioritize the statistical functions of AHRQ” and argues that some research duplicates work elsewhere within HHS.

For infection prevention and control (IPC) professionals, the immediate question is which activities would absorb that reduction. The proposal does not identify specific HAI prevention grants or toolkits for cancellation. It therefore does not establish that a particular hospital’s infection prevention initiative has lost funding.

AHRQ’s connection to IPC is substantial. Its Safety Program for Healthcare-Associated Infection Prevention brings together evidence-based toolkits for intensive care and other hospital units. The program builds on Comprehensive Unit-based Safety Program methods, addressing central line-associated bloodstream infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia and events.

Those resources address an operational challenge familiar to infection preventionists: translating evidence into consistent bedside practice. The Toolkit for Preventing CLABSI and CAUTI in ICUs from AHRQ. combines clinical interventions with approaches to teamwork and safety culture. Its CAUTI resources also address implementation and sustainability, helping hospitals organize improvement efforts rather than simply distribute recommendations.

That work explains why an agency-level reduction warrants attention even without a confirmed list of affected IPC projects. Potential consequences could include fewer future research awards or reduced implementation support if those activities bear the brunt of the cuts. These are possible effects, not documented outcomes of this announcement.

The larger refugee services reduction raises a separate question about access to preventive care. CDC describes domestic refugee screening as an opportunity to identify health concerns and connect patients with ongoing care. Its guidance includes tuberculosis, immunizations, HIV, and viral hepatitis, with screening generally occurring 30 to 90 days after arrival.

However, the rescission document does not specify how much of the refugee-account reduction would affect medical screening or related services. Any connection to delayed diagnosis, vaccination gaps, or increased hospital demand remains conditional on actual service changes. Immigration status alone should not be treated as evidence of infection risk.

The funding mechanism is also disputed. A pocket rescission involves proposing cancellation near the fiscal year’s end, potentially allowing funds to expire before Congress can act. In its explanation of the practice, the Government Accountability Office states, “The Impoundment Control Act (ICA) does not provide that authority.”

The Associated Press reported that Senate Appropriations Committee Chair Susan Collins opposed the administration’s action. That dispute over spending authority is distinct from the question of which individual health programs would undergo operational changes.

For IPC leaders, a practical response is to identify dependence on AHRQ-funded projects, ask research and finance teams about award-specific notices, and confirm whether community partners anticipate service interruptions. Existing prevention practices should continue while organizations seek concrete information.

Hospitals can also document what implementation support contributes locally, including staff education, teamwork, and sustained use of prevention protocols. Such information would help distinguish a general budget concern from a measurable operational gap.

The central issue in infection prevention is continuity: whether the research, practical tools, and partnerships that support safer care remain available. Answering that requires program-level decisions and communication with affected organizations, not assumptions based solely on the headline dollar amount.